Symbols / SXTC $1.86 -1.59% China SXT Pharmaceuticals, Inc.
SXTC Chart
About
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 1.59M |
| Enterprise Value | -18.64M | Income | -8.87M | Sales | 1.54M |
| Book/sh | 26.16 | Cash/sh | 27.55 | Dividend Yield | — |
| Payout | 0.00% | Employees | 75 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 1.03 | P/B | 0.07 | P/C | — |
| EV/EBITDA | 2.24 | EV/Sales | -12.12 | Quick Ratio | 4.04 |
| Current Ratio | 4.37 | Debt/Eq | 5.95 | LT Debt/Eq | — |
| EPS (ttm) | -57.15 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -24.50% | Earnings | — | ROA | -18.27% |
| ROE | -50.30% | ROIC | — | Gross Margin | 21.74% |
| Oper. Margin | -10.12% | Profit Margin | 0.00% | Shs Outstand | 853.51K |
| Shs Float | 547.05K | Short Float | 3.70% | Short Ratio | 0.53 |
| Short Interest | — | 52W High | 1047.00 | 52W Low | 1.25 |
| Beta | 1.75 | Avg Volume | 318.49K | Volume | 53.82K |
| Target Price | — | Recom | None | Prev Close | $1.89 |
| Price | $1.86 | Change | -1.59% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- What China SXT's 1-for-150 share consolidation means for holders - Stock Titan Fri, 30 Jan 2026 08
- China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering of Class A Ordinary Shares - Quiver Quantitative Fri, 09 Jan 2026 08
- Here’s Why China SXT Pharmaceuticals Stock (SXTC) Rocketed Today - tipranks.com Mon, 02 Feb 2026 08
- This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off? - Stocktwits Fri, 30 Jan 2026 08
- +39% after hours Most Active: SXTC China SXT Pharm NASDAQ 02/02/26: watch float - Meyka Mon, 02 Feb 2026 08
- China SXT gives new Class B shares 50 votes each in reclassification - Stock Titan Mon, 23 Mar 2026 07
- China SXT Pharmaceuticals, Inc. Announces Share Re-classification - Sahm Mon, 23 Mar 2026 07
- China SXT Pharmaceuticals implements dual-class share structure - Investing.com Mon, 23 Mar 2026 07
- China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewswire Fri, 30 Jan 2026 08
- China SXT Pharmaceuticals Announces Reverse Stock Split - StocksToTrade Mon, 09 Feb 2026 08
- This nano-cap pharma stock crashed 30% today – what triggered the sell-off? - MSN Fri, 30 Jan 2026 18
- SXTC Stock Soars Amid Strategic AI Initiative Expansion - timothysykes.com Fri, 09 Jan 2026 08
- China SXT Pharmaceuticals Launches Strategic Artificial Intelligence Insights Initiative to Enhance TCM Product Development and Market Intelligence - Quiver Quantitative hu, 08 Jan 2026 08
- Why Is Penny Stock China SXT (SXTC) Up Almost 200% Today? - tipranks.com hu, 08 Jan 2026 08
- Why one investor agreed to buy 66,666,666 shares of this drugmaker - Stock Titan Fri, 09 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
1.74
-9.73%
|
1.93
-2.19%
|
1.97
-24.23%
|
2.60
|
| Operating Revenue |
|
1.74
-9.73%
|
1.93
-2.19%
|
1.97
-24.23%
|
2.60
|
| Cost Of Revenue |
|
1.37
-0.08%
|
1.37
-11.06%
|
1.55
+14.42%
|
1.35
|
| Reconciled Cost Of Revenue |
|
1.37
-0.08%
|
1.37
-11.06%
|
1.55
+14.42%
|
1.35
|
| Gross Profit |
|
0.37
-33.67%
|
0.55
+29.96%
|
0.43
-65.94%
|
1.25
|
| Operating Expense |
|
3.05
-0.69%
|
3.07
-49.13%
|
6.03
-6.33%
|
6.44
|
| Selling General And Administration |
|
3.05
-0.69%
|
3.07
-49.13%
|
6.03
-6.33%
|
6.44
|
| Selling And Marketing Expense |
|
0.29
-33.15%
|
0.43
+11.90%
|
0.39
-58.09%
|
0.92
|
| General And Administrative Expense |
|
2.76
+4.65%
|
2.64
-53.32%
|
5.65
+2.35%
|
5.52
|
| Other Gand A |
|
2.76
+4.65%
|
2.64
-53.32%
|
5.65
+2.35%
|
5.52
|
| Total Expenses |
|
4.42
-0.50%
|
4.44
-41.37%
|
7.58
-2.73%
|
7.79
|
| Operating Income |
|
-2.68
-6.57%
|
-2.52
+55.15%
|
-5.61
-8.05%
|
-5.19
|
| Total Operating Income As Reported |
|
-2.68
-6.57%
|
-2.52
+55.15%
|
-5.61
-8.05%
|
-5.19
|
| EBITDA |
|
-2.57
-9.45%
|
-2.35
+54.86%
|
-5.21
-3.10%
|
-5.05
|
| Normalized EBITDA |
|
-2.57
-9.45%
|
-2.35
+54.86%
|
-5.21
-3.10%
|
-5.05
|
| Reconciled Depreciation |
|
0.08
-59.51%
|
0.20
-18.75%
|
0.25
-21.83%
|
0.32
|
| EBIT |
|
-2.66
-3.96%
|
-2.55
+53.20%
|
-5.46
-1.61%
|
-5.37
|
| Total Unusual Items |
|
—
|
—
|
—
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
—
|
0.00
|
| Special Income Charges |
|
—
|
—
|
—
|
0.00
|
| Net Income |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Pretax Income |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-9.74%
|
-5.41
|
| Net Non Operating Interest Income Expense |
|
-0.65
-19.10%
|
-0.54
-14.16%
|
-0.48
-1199.29%
|
-0.04
|
| Interest Expense Non Operating |
|
0.65
+19.10%
|
0.54
+14.16%
|
0.48
+1199.29%
|
0.04
|
| Net Interest Income |
|
-0.65
-19.10%
|
-0.54
-14.16%
|
-0.48
-1199.29%
|
-0.04
|
| Interest Expense |
|
0.65
+19.10%
|
0.54
+14.16%
|
0.48
+1199.29%
|
0.04
|
| Other Income Expense |
|
0.03
+164.17%
|
-0.04
-126.11%
|
0.15
+182.34%
|
-0.18
|
| Other Non Operating Income Expenses |
|
0.03
+164.17%
|
-0.04
-126.11%
|
0.15
+182.34%
|
-0.18
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.33
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Net Income From Continuing Operation Net Minority Interest |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Net Income From Continuing And Discontinued Operation |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Net Income Continuous Operations |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Normalized Income |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Net Income Common Stockholders |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Diluted EPS |
|
-348.15
+79.24%
|
-1,676.69
+89.24%
|
-15,576.83
+81.81%
|
-85,613.36
|
| Basic EPS |
|
-348.15
+79.24%
|
-1,676.69
+89.24%
|
-15,576.83
+81.81%
|
-85,613.36
|
| Basic Average Shares |
|
0.01
+413.42%
|
0.00
+385.04%
|
0.00
+468.66%
|
0.00
|
| Diluted Average Shares |
|
0.01
+413.42%
|
0.00
+385.04%
|
0.00
+468.66%
|
0.00
|
| Diluted NI Availto Com Stockholders |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Total Other Finance Cost |
|
—
|
—
|
0.48
+1199.29%
|
0.04
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets |
|
21.66
-6.33%
|
23.13
-21.75%
|
29.55
-11.90%
|
33.55
|
| Current Assets |
|
21.30
+49.62%
|
14.23
-27.09%
|
19.52
-13.05%
|
22.45
|
| Cash Cash Equivalents And Short Term Investments |
|
18.10
+49.95%
|
12.07
-30.50%
|
17.37
+11.88%
|
15.52
|
| Cash And Cash Equivalents |
|
18.10
+49.95%
|
12.07
-30.50%
|
17.37
+11.88%
|
15.52
|
| Receivables |
|
1.90
+41.13%
|
1.35
-14.52%
|
1.58
-72.91%
|
5.81
|
| Accounts Receivable |
|
1.30
-1.02%
|
1.31
-2.22%
|
1.34
-59.66%
|
3.33
|
| Gross Accounts Receivable |
|
3.38
+11.08%
|
3.05
+6.24%
|
2.87
-30.00%
|
4.10
|
| Allowance For Doubtful Accounts Receivable |
|
-2.08
-20.27%
|
-1.73
-13.71%
|
-1.52
-99.57%
|
-0.76
|
| Receivables Adjustments Allowances |
|
-0.47
+0.50%
|
-0.47
+0.92%
|
-0.47
|
0.00
|
| Other Receivables |
|
0.52
+4.51%
|
0.50
-22.46%
|
0.65
-23.98%
|
0.85
|
| Accrued Interest Receivable |
|
—
|
—
|
0.00
-100.00%
|
0.08
|
| Loans Receivable |
|
0.12
|
0.00
|
0.00
-100.00%
|
1.50
|
| Inventory |
|
0.83
+4.18%
|
0.79
+49.62%
|
0.53
-47.79%
|
1.02
|
| Raw Materials |
|
0.44
+35.88%
|
0.32
+31.86%
|
0.24
-59.79%
|
0.60
|
| Finished Goods |
|
0.45
-18.97%
|
0.55
+23.90%
|
0.45
-23.58%
|
0.58
|
| Prepaid Assets |
|
0.44
+2844.93%
|
0.01
-67.82%
|
0.05
-7.97%
|
0.05
|
| Current Deferred Assets |
|
—
|
—
|
—
|
0.00
|
| Restricted Cash |
|
0.03
+344.50%
|
0.01
|
0.00
-100.00%
|
0.05
|
| Other Current Assets |
|
—
|
—
|
—
|
0.29
|
| Total Non Current Assets |
|
0.37
-95.87%
|
8.89
-11.35%
|
10.03
-9.57%
|
11.09
|
| Net PPE |
|
0.36
-37.10%
|
0.56
-55.48%
|
1.27
-20.28%
|
1.59
|
| Gross PPE |
|
2.94
-4.84%
|
3.09
-4.67%
|
3.25
-4.87%
|
3.41
|
| Accumulated Depreciation |
|
-2.59
-2.36%
|
-2.53
-27.91%
|
-1.98
-8.60%
|
-1.82
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.34
-0.50%
|
0.34
-4.88%
|
0.36
|
0.00
|
| Machinery Furniture Equipment |
|
0.90
-13.98%
|
1.05
-4.24%
|
1.09
-1.32%
|
1.11
|
| Construction In Progress |
|
—
|
—
|
0.00
-100.00%
|
0.36
|
| Other Properties |
|
0.14
-0.50%
|
0.14
-4.88%
|
0.15
-7.69%
|
0.16
|
| Leases |
|
1.56
-0.07%
|
1.56
-4.88%
|
1.64
-7.69%
|
1.78
|
| Goodwill And Other Intangible Assets |
|
0.01
-38.18%
|
0.02
-31.46%
|
0.03
-28.10%
|
0.04
|
| Other Intangible Assets |
|
0.01
-38.18%
|
0.02
-31.46%
|
0.03
-28.10%
|
0.04
|
| Non Current Deferred Assets |
|
—
|
—
|
—
|
0.00
|
| Non Current Deferred Taxes Assets |
|
—
|
—
|
—
|
0.00
|
| Non Current Prepaid Assets |
|
0.00
-100.00%
|
8.31
-4.88%
|
8.74
-7.69%
|
9.46
|
| Total Liabilities Net Minority Interest |
|
6.22
-32.33%
|
9.20
-38.12%
|
14.86
-13.19%
|
17.12
|
| Current Liabilities |
|
6.01
-32.46%
|
8.90
-38.59%
|
14.50
-15.33%
|
17.12
|
| Payables And Accrued Expenses |
|
4.45
-23.04%
|
5.79
-42.36%
|
10.04
-32.51%
|
14.88
|
| Payables |
|
3.35
-26.56%
|
4.56
-49.83%
|
9.09
-35.20%
|
14.03
|
| Accounts Payable |
|
1.16
-9.47%
|
1.28
-7.14%
|
1.38
-7.04%
|
1.48
|
| Other Payable |
|
1.16
-1.81%
|
1.18
-15.87%
|
1.40
-47.69%
|
2.68
|
| Current Accrued Expenses |
|
1.10
-9.96%
|
1.23
+29.14%
|
0.95
+12.12%
|
0.85
|
| Total Tax Payable |
|
1.03
-2.00%
|
1.05
-4.74%
|
1.10
-5.38%
|
1.17
|
| Current Debt And Capital Lease Obligation |
|
0.77
-67.18%
|
2.35
-30.61%
|
3.39
+65.70%
|
2.05
|
| Current Debt |
|
0.71
-69.01%
|
2.29
-31.15%
|
3.33
+62.87%
|
2.05
|
| Other Current Borrowings |
|
0.71
-69.01%
|
2.29
-31.15%
|
3.33
+62.87%
|
2.05
|
| Current Capital Lease Obligation |
|
0.06
+5.01%
|
0.06
+0.38%
|
0.06
|
0.00
|
| Current Deferred Liabilities |
|
0.06
-68.76%
|
0.19
+13.37%
|
0.17
+113.96%
|
0.08
|
| Current Deferred Revenue |
|
0.06
-68.76%
|
0.19
+13.37%
|
0.17
+113.96%
|
0.08
|
| Other Current Liabilities |
|
0.67
+86.53%
|
0.36
-54.19%
|
0.79
-32.10%
|
1.16
|
| Total Non Current Liabilities Net Minority Interest |
|
0.21
-28.16%
|
0.29
-19.45%
|
0.37
|
0.00
|
| Long Term Debt And Capital Lease Obligation |
|
0.21
-28.16%
|
0.29
-19.45%
|
0.37
|
0.00
|
| Long Term Debt |
|
0.10
-17.81%
|
0.12
-0.62%
|
0.12
|
—
|
| Long Term Capital Lease Obligation |
|
0.12
-34.99%
|
0.18
-28.40%
|
0.25
|
0.00
|
| Stockholders Equity |
|
15.44
+10.83%
|
13.93
-5.18%
|
14.69
-10.55%
|
16.42
|
| Common Stock Equity |
|
15.44
+10.83%
|
13.93
-5.18%
|
14.69
-10.55%
|
16.42
|
| Capital Stock |
|
44.53
+923.15%
|
4.35
+376.29%
|
0.91
+462.44%
|
0.16
|
| Common Stock |
|
44.53
+923.15%
|
4.35
+376.29%
|
0.91
+462.44%
|
0.16
|
| Share Issued |
|
0.09
+4865.10%
|
0.00
+385.04%
|
0.00
+468.66%
|
0.00
|
| Ordinary Shares Number |
|
0.09
+4865.10%
|
0.00
+385.04%
|
0.00
+468.66%
|
0.00
|
| Additional Paid In Capital |
|
0.00
-100.00%
|
35.32
-0.77%
|
35.59
+14.82%
|
30.99
|
| Retained Earnings |
|
-28.02
-13.37%
|
-24.71
-14.34%
|
-21.61
-37.77%
|
-15.69
|
| Gains Losses Not Affecting Retained Earnings |
|
-1.08
-4.85%
|
-1.03
-419.20%
|
-0.20
-120.66%
|
0.96
|
| Other Equity Adjustments |
|
-1.08
-4.85%
|
-1.03
-419.20%
|
-0.20
-120.66%
|
0.96
|
| Total Equity Gross Minority Interest |
|
15.44
+10.83%
|
13.93
-5.18%
|
14.69
-10.55%
|
16.42
|
| Total Capitalization |
|
15.54
+10.60%
|
14.05
-5.14%
|
14.81
-9.84%
|
16.42
|
| Working Capital |
|
15.28
+186.69%
|
5.33
+6.11%
|
5.02
-5.74%
|
5.33
|
| Invested Capital |
|
16.25
-0.58%
|
16.34
-9.92%
|
18.14
-1.78%
|
18.47
|
| Total Debt |
|
0.98
-62.84%
|
2.65
-29.53%
|
3.76
+83.58%
|
2.05
|
| Capital Lease Obligations |
|
0.18
-25.10%
|
0.24
-22.94%
|
0.31
|
0.00
|
| Net Tangible Assets |
|
15.43
+10.90%
|
13.91
-5.13%
|
14.66
-10.51%
|
16.39
|
| Tangible Book Value |
|
15.43
+10.90%
|
13.91
-5.13%
|
14.66
-10.51%
|
16.39
|
| Current Provisions |
|
0.05
-74.77%
|
0.21
+90.77%
|
0.11
-8.81%
|
0.12
|
| Duefrom Related Parties Current |
|
0.42
|
0.00
-100.00%
|
0.06
+274.69%
|
0.02
|
| Dueto Related Parties Current |
|
0.00
-100.00%
|
1.05
-79.87%
|
5.20
-40.16%
|
8.70
|
| Inventories Adjustments Allowances |
|
-0.06
+29.08%
|
-0.08
+49.92%
|
-0.16
+7.69%
|
-0.17
|
| Notes Receivable |
|
—
|
—
|
0.00
-100.00%
|
0.04
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-2.35
-21.64%
|
-1.93
-2287.47%
|
-0.08
-130.10%
|
0.27
|
| Cash Flow From Continuing Operating Activities |
|
-2.35
-21.64%
|
-1.93
-2287.47%
|
-0.08
-130.10%
|
0.27
|
| Net Income From Continuing Operations |
|
-3.30
-6.62%
|
-3.10
+47.79%
|
-5.93
-3.46%
|
-5.74
|
| Depreciation Amortization Depletion |
|
0.08
-59.51%
|
0.20
-18.75%
|
0.25
-21.83%
|
0.32
|
| Depreciation |
|
0.08
-61.66%
|
0.20
|
—
|
—
|
| Amortization Cash Flow |
|
0.01
-2.96%
|
0.01
|
—
|
—
|
| Depreciation And Amortization |
|
0.08
-59.51%
|
0.20
-18.75%
|
0.25
-21.83%
|
0.32
|
| Amortization Of Intangibles |
|
0.01
-2.96%
|
0.01
|
—
|
—
|
| Other Non Cash Items |
|
1.60
+340.22%
|
0.36
-11.28%
|
0.41
-30.51%
|
0.59
|
| Stock Based Compensation |
|
0.00
-100.00%
|
0.35
-36.51%
|
0.55
-76.24%
|
2.33
|
| Provisionand Write Offof Assets |
|
0.26
-6.80%
|
0.28
-90.15%
|
2.88
+502.49%
|
0.48
|
| Asset Impairment Charge |
|
-0.02
-106.52%
|
0.35
+0.42%
|
0.35
+554.72%
|
0.05
|
| Deferred Tax |
|
—
|
0.00
|
0.00
-100.00%
|
0.33
|
| Deferred Income Tax |
|
—
|
0.00
|
0.00
-100.00%
|
0.33
|
| Operating Gains Losses |
|
0.01
|
—
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.01
|
0.00
|
0.00
|
—
|
| Change In Working Capital |
|
-0.97
-154.67%
|
-0.38
-126.96%
|
1.42
-25.62%
|
1.90
|
| Change In Receivables |
|
-0.48
-169.60%
|
-0.18
-117.89%
|
1.00
+25.08%
|
0.80
|
| Changes In Account Receivables |
|
-0.26
+20.02%
|
-0.32
-135.21%
|
0.91
+9.80%
|
0.83
|
| Change In Inventory |
|
-0.01
+93.38%
|
-0.22
-153.71%
|
0.41
+326.19%
|
-0.18
|
| Change In Prepaid Assets |
|
-0.29
-1080.46%
|
0.03
+21172.46%
|
0.00
-99.99%
|
1.50
|
| Change In Payables And Accrued Expense |
|
0.17
+307.10%
|
-0.08
-747.65%
|
-0.01
-102.91%
|
0.33
|
| Change In Accrued Expense |
|
0.30
+654.96%
|
-0.05
-16.09%
|
-0.05
-112.05%
|
0.38
|
| Change In Payable |
|
-0.13
-369.17%
|
-0.03
-175.34%
|
0.04
+167.08%
|
-0.05
|
| Change In Account Payable |
|
-0.11
-289.97%
|
-0.03
-401.59%
|
0.01
+142.56%
|
-0.02
|
| Change In Other Working Capital |
|
-0.13
-523.16%
|
0.03
-67.73%
|
0.09
+150.61%
|
-0.19
|
| Change In Other Current Liabilities |
|
-0.23
-701.21%
|
0.04
+151.15%
|
-0.07
+79.38%
|
-0.36
|
| Investing Cash Flow |
|
0.06
+140.38%
|
0.03
+314.77%
|
-0.01
+73.77%
|
-0.05
|
| Cash Flow From Continuing Investing Activities |
|
0.06
+140.38%
|
0.03
+314.77%
|
-0.01
+73.77%
|
-0.05
|
| Net PPE Purchase And Sale |
|
0.06
+999.28%
|
-0.01
+90.01%
|
-0.07
-13.11%
|
-0.06
|
| Purchase Of PPE |
|
-0.00
+71.36%
|
-0.01
+90.01%
|
-0.07
-13.11%
|
-0.06
|
| Sale Of PPE |
|
0.07
|
0.00
|
0.00
|
—
|
| Capital Expenditure |
|
-0.00
+71.36%
|
-0.01
+90.01%
|
-0.07
-13.11%
|
-0.06
|
| Net Investment Purchase And Sale |
|
—
|
—
|
0.00
|
0.00
|
| Purchase Of Investment |
|
—
|
—
|
0.00
|
0.00
|
| Net Intangibles Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Purchase Of Intangibles |
|
—
|
—
|
—
|
0.00
|
| Net Other Investing Changes |
|
—
|
0.03
-42.64%
|
0.06
+274.69%
|
0.02
|
| Financing Cash Flow |
|
8.40
+420.04%
|
-2.62
-189.22%
|
2.94
+84.41%
|
1.60
|
| Cash Flow From Continuing Financing Activities |
|
8.40
+420.04%
|
-2.62
-189.22%
|
2.94
+84.41%
|
1.60
|
| Net Issuance Payments Of Debt |
|
-0.07
-104.59%
|
1.42
-64.58%
|
4.00
+44.49%
|
2.77
|
| Issuance Of Debt |
|
1.85
+23.76%
|
1.50
-62.86%
|
4.03
+43.72%
|
2.80
|
| Repayment Of Debt |
|
-1.92
-2338.68%
|
-0.08
-201.29%
|
-0.03
+21.02%
|
-0.03
|
| Long Term Debt Issuance |
|
1.85
+23.76%
|
1.50
-62.86%
|
4.03
+43.72%
|
2.80
|
| Long Term Debt Payments |
|
-1.92
-2338.68%
|
-0.08
-201.29%
|
-0.03
+21.02%
|
-0.03
|
| Net Long Term Debt Issuance |
|
-0.07
-104.59%
|
1.42
-64.58%
|
4.00
+44.49%
|
2.77
|
| Short Term Debt Issuance |
|
—
|
—
|
3.72
+32.69%
|
2.80
|
| Short Term Debt Payments |
|
—
|
—
|
0.00
|
0.00
|
| Net Short Term Debt Issuance |
|
—
|
—
|
0.00
|
0.00
|
| Net Common Stock Issuance |
|
2.76
|
0.00
-100.00%
|
2.19
-29.54%
|
3.12
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
|
0.00
+100.00%
|
-0.03
|
| Net Other Financing Charges |
|
5.70
+241.09%
|
-4.04
-24.09%
|
-3.26
+23.55%
|
-4.26
|
| Changes In Cash |
|
6.12
+235.16%
|
-4.53
-258.89%
|
2.85
+56.81%
|
1.82
|
| Effect Of Exchange Rate Changes |
|
-0.07
+91.49%
|
-0.77
+27.10%
|
-1.05
-366.34%
|
0.39
|
| Beginning Cash Position |
|
12.08
-30.46%
|
17.37
+11.55%
|
15.57
+16.55%
|
13.36
|
| End Cash Position |
|
18.13
+50.11%
|
12.08
-30.46%
|
17.37
+11.55%
|
15.57
|
| Free Cash Flow |
|
-2.35
-21.30%
|
-1.94
-1177.80%
|
-0.15
-173.59%
|
0.21
|
| Interest Paid Supplemental Data |
|
0.02
-13.43%
|
0.02
+88.04%
|
0.01
+308.10%
|
0.00
|
| Income Tax Paid Supplemental Data |
|
—
|
0.00
|
0.00
-100.00%
|
0.02
|
| Change In Income Tax Payable |
|
-0.02
-1114.21%
|
0.00
-94.23%
|
0.03
+184.55%
|
-0.03
|
| Change In Tax Payable |
|
-0.02
-1114.21%
|
0.00
-94.23%
|
0.03
+184.55%
|
-0.03
|
| Common Stock Issuance |
|
2.76
|
0.00
-100.00%
|
2.19
-29.54%
|
3.12
|
| Issuance Of Capital Stock |
|
2.76
|
0.00
-100.00%
|
2.19
-29.54%
|
3.12
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|